Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Cytokinetics Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Foghorn Therapeutics Inc. June 24, 202696.3%
-
Cytokinetics Incorporated May 14, 202596.7%
-
Foghorn Therapeutics Inc. June 21, 202399.9%
-
Ionis Pharmaceuticals Inc. June 1, 202384.6%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $71.48 | $357,400 |
| Jun 1, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $74.08 | $370,400 |
| May 27, 2026 | Cytokinetics Incorporated | Grant or award | +2,851 | — | — |
| Apr 15, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −4,466 | $76.19 | $340,265 |
| Apr 15, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −534 | $76.97 | $41,102 |
| Mar 2, 2026 | Cytokinetics Incorporated | Open-market sale | −5,000 | $61.21 | $306,050 |
| Feb 11, 2026 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,000 | $82.72 | $413,600 |
| Nov 19, 2025 | Cytokinetics Incorporated | Open-market sale | −5,000 | $64.73 | $323,650 |
| Oct 15, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −5,000 | $71.74 | $358,700 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −10,750 | $50.42 | $542,015 |
| Sep 2, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −9,250 | $51.49 | $476,283 |
| Aug 6, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −4,600 | $41.87 | $192,602 |
| Aug 6, 2025 | Ionis Pharmaceuticals Inc. | Open-market sale | −400 | $42.63 | $17,052 |
| Jul 15, 2025 | Ionis Pharmaceuticals Inc. | Option exercise | +4,079 | — | — |
| May 14, 2025 | Cytokinetics Incorporated | Grant or award | +7,333 | — | — |
Questions about B. Lynne Parshall
What boards is B. Lynne Parshall on?
B. Lynne Parshall sits on the boards of Cytokinetics Incorporated, Foghorn Therapeutics Inc. and Ionis Pharmaceuticals Inc.
How long has B. Lynne Parshall served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.